Patents and Generics.pptx
•Download as PPTX, PDF•
0 likes•76 views
Generic drugs are cheaper than branded drugs because generic manufacturers do not incur the substantial research and development costs associated with bringing a new drug to market. When a company develops a new drug, they receive a patent that grants them exclusive rights to sell that drug for a period of time in order to recoup their investment costs. Metformin and metoprolol are examples of generic drugs that treat diabetes and hypertension, respectively, while Glucophage and Lopressor are the branded versions of those drugs.
Report
Share
Report
Share
Recommended
Generic drugs and their importance
Generic drugs contain the same active ingredients and are equivalent to their brand name counterparts. They are allowed for sale after the original drug patent expires. Generics are usually cheaper than brands because generic manufacturers don't have the same research and development costs as brand manufacturers. The FDA requires generics to have the same clinical effects as their brand versions.
Pharmaceutical Industry - Business Perspectives for IT Teams
The document provides an overview of the pharmaceutical industry and drug development process. It discusses how the industry is highly regulated and the various stages of drug development from target discovery through clinical trials and regulatory approval. It also outlines the major areas of pharmaceutical manufacturing including biochemical and chemical API production, bulk manufacturing, and packaging. Regulatory compliance and good manufacturing practices are essential throughout the manufacturing process.
" GENERIC MEDICINE''
The document discusses generic medicines and their evolution. It notes that generic medicines provide significant economic advantages to consumers and the pharmaceutical industry by decreasing drug prices after brand name patents expire. Approximately 50% of prescriptions in many countries are now filled by lower cost generic drugs. The generic drug market in India, which supplies over 30% of the global generic market, is growing substantially and expected to reach $72 billion by 2020. While generic drugs must demonstrate bioequivalence to the brand name version, they provide significant cost savings over branded drugs for both consumers and healthcare systems.
Brand drug vs generic drug
This document discusses brand name drugs and generic drugs. It provides definitions and examples to compare the two. Brand name drugs are invented by pharmaceutical companies, while generic drugs have the same active ingredients but can differ in inactive ingredients and formulation. Generic drugs are approved through an Abbreviated New Drug Application to the FDA which requires bioequivalence testing. The document outlines the FDA approval process and regulations for both brand name and generic drugs to be equivalent in quality, safety and efficacy. It also discusses factors like research costs that contribute to higher prices of brand name drugs compared to generics.
Patents and Generic.pptx
Patent and Generic Pharmaceutical Ethics
When a new drug is developed, the pharmaceutical company is initially granted a patent for around 20 years to exclusively sell the drug under a brand name. Once the patent expires, generic drug companies can produce versions of the drug. Generics must be proven to be equivalent to the brand version in dosage, safety, and performance to gain FDA approval. This increased competition brings drug prices down substantially, improving access and affordability for patients.
Patents and Generic.pptx
Patent and Generic Pharmaceutical Ethics
When a new drug is developed, the pharmaceutical company is initially granted a patent for around 20 years to exclusively sell the drug under a brand name. Once the patent expires, generic drug companies can produce versions of the drug. Generics must be proven to be equivalent to the brand version in dosage, safety, and performance to gain FDA approval. This increased competition brings drug prices down substantially, improving access and affordability for patients.
What are Generic medicines ????
Generic medicines provide an affordable alternative to expensive branded medicines. They contain the same active ingredients but are significantly cheaper because generic manufacturers do not incur research and development costs. Generic medicines allow people to cut their monthly medical expenses substantially. While branded drugs are often heavily promoted, generic drugs are equally effective and safe as they must meet the same quality standards set by regulatory bodies. Doctors sometimes preferentially prescribe branded drugs due to agreements with pharmaceutical companies, but generic drugs offer patients more choice and savings without compromising quality of care.
What you want to know about generic drugs
This document discusses generic drugs and the FDA approval process. It aims to dispel myths about generic drugs by explaining that generics are as safe and effective as brand name drugs and must meet the same standards. The FDA reviews generics rigorously to confirm quality, safety and effectiveness. Further, the document outlines efforts by the FDA and government to increase availability and affordability of generic drugs.
Recommended
Generic drugs and their importance
Generic drugs contain the same active ingredients and are equivalent to their brand name counterparts. They are allowed for sale after the original drug patent expires. Generics are usually cheaper than brands because generic manufacturers don't have the same research and development costs as brand manufacturers. The FDA requires generics to have the same clinical effects as their brand versions.
Pharmaceutical Industry - Business Perspectives for IT Teams
The document provides an overview of the pharmaceutical industry and drug development process. It discusses how the industry is highly regulated and the various stages of drug development from target discovery through clinical trials and regulatory approval. It also outlines the major areas of pharmaceutical manufacturing including biochemical and chemical API production, bulk manufacturing, and packaging. Regulatory compliance and good manufacturing practices are essential throughout the manufacturing process.
" GENERIC MEDICINE''
The document discusses generic medicines and their evolution. It notes that generic medicines provide significant economic advantages to consumers and the pharmaceutical industry by decreasing drug prices after brand name patents expire. Approximately 50% of prescriptions in many countries are now filled by lower cost generic drugs. The generic drug market in India, which supplies over 30% of the global generic market, is growing substantially and expected to reach $72 billion by 2020. While generic drugs must demonstrate bioequivalence to the brand name version, they provide significant cost savings over branded drugs for both consumers and healthcare systems.
Brand drug vs generic drug
This document discusses brand name drugs and generic drugs. It provides definitions and examples to compare the two. Brand name drugs are invented by pharmaceutical companies, while generic drugs have the same active ingredients but can differ in inactive ingredients and formulation. Generic drugs are approved through an Abbreviated New Drug Application to the FDA which requires bioequivalence testing. The document outlines the FDA approval process and regulations for both brand name and generic drugs to be equivalent in quality, safety and efficacy. It also discusses factors like research costs that contribute to higher prices of brand name drugs compared to generics.
Patents and Generic.pptx
Patent and Generic Pharmaceutical Ethics
When a new drug is developed, the pharmaceutical company is initially granted a patent for around 20 years to exclusively sell the drug under a brand name. Once the patent expires, generic drug companies can produce versions of the drug. Generics must be proven to be equivalent to the brand version in dosage, safety, and performance to gain FDA approval. This increased competition brings drug prices down substantially, improving access and affordability for patients.
Patents and Generic.pptx
Patent and Generic Pharmaceutical Ethics
When a new drug is developed, the pharmaceutical company is initially granted a patent for around 20 years to exclusively sell the drug under a brand name. Once the patent expires, generic drug companies can produce versions of the drug. Generics must be proven to be equivalent to the brand version in dosage, safety, and performance to gain FDA approval. This increased competition brings drug prices down substantially, improving access and affordability for patients.
What are Generic medicines ????
Generic medicines provide an affordable alternative to expensive branded medicines. They contain the same active ingredients but are significantly cheaper because generic manufacturers do not incur research and development costs. Generic medicines allow people to cut their monthly medical expenses substantially. While branded drugs are often heavily promoted, generic drugs are equally effective and safe as they must meet the same quality standards set by regulatory bodies. Doctors sometimes preferentially prescribe branded drugs due to agreements with pharmaceutical companies, but generic drugs offer patients more choice and savings without compromising quality of care.
What you want to know about generic drugs
This document discusses generic drugs and the FDA approval process. It aims to dispel myths about generic drugs by explaining that generics are as safe and effective as brand name drugs and must meet the same standards. The FDA reviews generics rigorously to confirm quality, safety and effectiveness. Further, the document outlines efforts by the FDA and government to increase availability and affordability of generic drugs.
Generic name
The document provides information about generic and brand name drugs, including:
1) Generic drugs have the same active ingredients as brand name drugs but are cheaper because they do not require extensive research and development costs.
2) While generics must be proven to deliver the same amount of active ingredients as brand names, they are allowed to have different inactive ingredients and appearances.
3) Choosing a generic over a brand name drug can significantly reduce out-of-pocket costs through lower co-pays and prices, though insurance plans may steer patients toward generics.
Single and Multiplle Source Drugs
When a drug patent expires, the FDA may grant a six-month exclusivity period to one company to produce the generic version. During this time it is a "single-source" generic drug, produced by only one manufacturer and priced higher than multi-source generics. After the exclusivity period expires, other manufacturers can produce generic versions, and the drug becomes "multi-source." Examples given include paracetamol, which is now available generically from many sources due to expired patents.
pharma regulatory a
This document provides an overview of the global generic pharmaceutical industry and the regulatory process for approving generic drugs in the United States. It discusses key topics such as:
1) The size and growth of the global generic market compared to the overall pharmaceutical industry.
2) How the Hatch-Waxman Act of 1984 streamlined the generic drug approval process in the US through the ANDA pathway.
3) Potential issues with the Hatch-Waxman Act around "evergreening" patents and deals between brand and generic companies that delay generic competition.
Swapnil2
The document provides an overview of the global pharmaceutical industry and the generic drug market. It discusses how the generic drug market is growing faster than the overall pharmaceutical industry. It also summarizes the key requirements for FDA approval of generic drugs, including bioequivalence to the branded version. Additionally, it outlines the Hatch-Waxman Act which aims to balance generic and branded drug competition in the US market.
Originators and Princeps: How to face Biosimilars and Generics
Concerning the levers a originators producer can put in place to face the biosimilars competition and maintain his position, benchmarking on biosimilars, generics (13 companies from 2000 to 2015) and the results of our interview allow us to observe 10 levers:
Price Prescription
Patent Market saturation
Legal action New market
Cooperation Environmental strategy
Product Brand strategy
Case study.pptx
This document discusses Dr. Reddy's Laboratories, an Indian pharmaceutical company founded in 1984. It operates in three segments: global generics, pharmaceutical services and active ingredients, and proprietary products. The global generics segment produces generic drugs, while the proprietary products segment focuses on developing differentiated formulations and new chemical entities in areas like dermatology and neurology. The document also outlines Dr. Reddy's vision, values, an analysis of Porter's five forces in the pharmaceutical industry, and opportunities and threats facing the company.
SCHEDULE W.pptx
The document discusses generic drugs and branded drugs in India. It notes that generic drugs are required to have the same active ingredients, dosage, quality, and therapeutic effects as branded drugs. Generic drugs are cheaper than branded drugs because generic manufacturers do not incur the costs of drug development and marketing that the original branded manufacturers did. The document provides several examples of generic drug brands in India and their prices, which are typically much lower than their branded equivalents.
Off label use of drugs
This document discusses off-label drug use, which refers to using approved drugs in ways not specified in the FDA approval. Common reasons for off-label use include therapeutic advances outpacing regulatory approval and lack of financial incentive for new trials. Up to 1/5 of prescriptions are off-label, including 31% of antipsychotics and 33% of anticancer drugs. Off-label use has pros like earlier access but also risks like increased adverse effects. Regulations vary by country, with physicians generally allowed to prescribe off-label but companies prohibited from promoting off-label uses. Increased expectations from patients call for rational, evidence-based off-label prescribing and safety monitoring.
Marketing Mix, PLC, SWOT Analysis - LIPITOR
A study research report on marketing mix, product life cycle and SWOT analysis for a iconic pharmaceutical brand, Lipitor.
Marketing of a pharma (Basic)
this is just powerpoint of the report on a pharma company this was to present in the class and for the ease to understand the research of principle of marketing in institute of business management IoBM
Case study on merck
Merck is facing losing patents on some major drugs like Vasotac and Mevacor. Possible solutions are mergers or focusing on innovation. Merck's new product process was previously slow to respond to competitors, but it now develops cross-functional teams early in the process. Developing specialized patented drugs helps Merck capture new markets. However, drug development faces risks if products fail trials or competitors launch first. The pharmaceutical industry faces challenges like patent expirations and increasing drug resistance. Porter's five forces analysis shows barriers to entry are high in pharmaceuticals due to R&D costs and required scale, while buyers have significant bargaining power.
Generic drug and WTO
Generic drugs provide the same clinical benefits as their brand-name counterparts at a lower cost. The document discusses the definition of generic drugs and the regulatory process for approval, including how generics are proven to be bioequivalent to the original drug but do not need to repeat clinical trials. It also addresses India's policies promoting generic drugs, the TRIPS agreement and its implications for international drug access, and initiatives like the Doha Declaration aimed at balancing intellectual property protections with public health needs.
Generic drug ppt
The document discusses the generic drug development process and the Hatch-Waxman Act. It defines generic drugs as being identical to brand name drugs in active ingredients, dosage form, quality and therapeutic effects. The generic drug approval process involves submitting an Abbreviated New Drug Application to the FDA that demonstrates bioequivalence to the brand name drug. The Hatch-Waxman Act established the modern system of generic drug regulation, providing incentives for generic drugs to gain FDA approval and compensating brand name drugs for patent time lost during regulatory review.
Drug medicine pharmaceuticals
This document defines and explains common terminology used in the pharmaceutical field. It discusses terms like drug, medicine, classifications of drugs and medicines. It also defines other key terms including monograms, patents, brand names, generic names, over-the-counter drugs, narcotic drugs, biological drugs, and the nature of drugs. Traditional and herbal medicines are also described. The document provides references for each terminology defined.
Eugene D. Fanning Center for Business Communication 01-01Men.docx
The document discusses Bayer Corporation's recall of products containing the ingredient phenylpropanolamine (PPA) due to health concerns raised by the FDA. It provides background on Bayer, describes the controversy around PPA and studies linking it to risks of hemorrhagic stroke. It outlines the FDA's process for evaluating drug risks and requesting voluntary recalls. When the FDA recommended discontinuing PPA use, some media incorrectly reported this as an outright ban, which failed to anticipate how this would impact perception of Bayer's Alka-Seltzer brand.
Are there reasons for believing that the profitability of the industry might ...
Are there reasons for believing that the profitability of the industry might ...Global Study Solutions - 9901366442
Managers in the pharmaceutical industry face both opportunities and threats due to a dynamic environment. Demand for pharmaceuticals has grown steadily for decades due to demographics and successful new drugs can be highly profitable. However, developing new drugs takes 10-15 years and costs $800 million on average, with many failing. Additionally, incumbent firms face challenges such as upcoming patent expirations, potential price controls, and reduced prices negotiated by large health providers.Drug Bulletin of Nepal
The document summarizes several important drug regulatory news and safety updates from regulatory authorities including Health Canada and the US FDA. It provides warnings and updates to healthcare professionals in Nepal about potential drug interactions and risks, including:
1) The risk of high anion gap metabolic acidosis with concomitant use of flucloxacillin and paracetamol.
2) The possible risk of hypothyroidism in infants given iodine-containing contrast agents.
3) The removal of a boxed warning about asthma deaths for medicines containing inhaled corticosteroids and long-acting beta agonists.
4) The rare risk of subacute cutaneous lupus erythematosus with proton
The science of hope
This document discusses the challenges and strategies for successful orphan drug development. It notes that despite small patient populations, orphan drug development has grown significantly due to regulatory incentives. However, orphan drug development faces challenges including difficulties designing studies due to lack of disease information, problems recruiting small patient populations, and regulatory complexities. The document recommends three strategies for overcoming these challenges: 1) partnering with experienced CROs knowledgeable in rare diseases, 2) engaging key opinion leaders to help with sites and education, and 3) allowing flexibility in protocols and budgets to address unexpected changes common in rare disease studies. Overall the document outlines the benefits and hurdles of orphan drug development and provides guidance on navigating clinical and regulatory obstacles.
Generic Drugs Michael Mc Namara May 12
The document discusses generic drugs and biosimilars. It provides biographical information about the speaker and outlines key questions about generics that will be addressed. Generic drugs are defined as comparable but not identical to brand name drugs in dosage, strength, quality and performance. Biosimilars are similar to biologic drugs but require more extensive testing than generics due to their complex nature. The market for generic drugs is large and growing, particularly in emerging markets, as major drugs lose patent protection.
Submodule 3.1 Final June 2007
This document discusses marketing strategies used by the pharmaceutical industry, including how they target physicians and consumers. It outlines common marketing tactics like the "4 P's" of product, price, promotion and placement. It also discusses how companies may indirectly influence prescribing through clinical guidelines and gifts/payments to physicians. The legal boundaries of promoting on-label versus off-label drug use are covered, as well as ethical standards to limit physician interactions with industry.
All info about Diabetes and how to control it.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
More Related Content
Similar to Patents and Generics.pptx
Generic name
The document provides information about generic and brand name drugs, including:
1) Generic drugs have the same active ingredients as brand name drugs but are cheaper because they do not require extensive research and development costs.
2) While generics must be proven to deliver the same amount of active ingredients as brand names, they are allowed to have different inactive ingredients and appearances.
3) Choosing a generic over a brand name drug can significantly reduce out-of-pocket costs through lower co-pays and prices, though insurance plans may steer patients toward generics.
Single and Multiplle Source Drugs
When a drug patent expires, the FDA may grant a six-month exclusivity period to one company to produce the generic version. During this time it is a "single-source" generic drug, produced by only one manufacturer and priced higher than multi-source generics. After the exclusivity period expires, other manufacturers can produce generic versions, and the drug becomes "multi-source." Examples given include paracetamol, which is now available generically from many sources due to expired patents.
pharma regulatory a
This document provides an overview of the global generic pharmaceutical industry and the regulatory process for approving generic drugs in the United States. It discusses key topics such as:
1) The size and growth of the global generic market compared to the overall pharmaceutical industry.
2) How the Hatch-Waxman Act of 1984 streamlined the generic drug approval process in the US through the ANDA pathway.
3) Potential issues with the Hatch-Waxman Act around "evergreening" patents and deals between brand and generic companies that delay generic competition.
Swapnil2
The document provides an overview of the global pharmaceutical industry and the generic drug market. It discusses how the generic drug market is growing faster than the overall pharmaceutical industry. It also summarizes the key requirements for FDA approval of generic drugs, including bioequivalence to the branded version. Additionally, it outlines the Hatch-Waxman Act which aims to balance generic and branded drug competition in the US market.
Originators and Princeps: How to face Biosimilars and Generics
Concerning the levers a originators producer can put in place to face the biosimilars competition and maintain his position, benchmarking on biosimilars, generics (13 companies from 2000 to 2015) and the results of our interview allow us to observe 10 levers:
Price Prescription
Patent Market saturation
Legal action New market
Cooperation Environmental strategy
Product Brand strategy
Case study.pptx
This document discusses Dr. Reddy's Laboratories, an Indian pharmaceutical company founded in 1984. It operates in three segments: global generics, pharmaceutical services and active ingredients, and proprietary products. The global generics segment produces generic drugs, while the proprietary products segment focuses on developing differentiated formulations and new chemical entities in areas like dermatology and neurology. The document also outlines Dr. Reddy's vision, values, an analysis of Porter's five forces in the pharmaceutical industry, and opportunities and threats facing the company.
SCHEDULE W.pptx
The document discusses generic drugs and branded drugs in India. It notes that generic drugs are required to have the same active ingredients, dosage, quality, and therapeutic effects as branded drugs. Generic drugs are cheaper than branded drugs because generic manufacturers do not incur the costs of drug development and marketing that the original branded manufacturers did. The document provides several examples of generic drug brands in India and their prices, which are typically much lower than their branded equivalents.
Off label use of drugs
This document discusses off-label drug use, which refers to using approved drugs in ways not specified in the FDA approval. Common reasons for off-label use include therapeutic advances outpacing regulatory approval and lack of financial incentive for new trials. Up to 1/5 of prescriptions are off-label, including 31% of antipsychotics and 33% of anticancer drugs. Off-label use has pros like earlier access but also risks like increased adverse effects. Regulations vary by country, with physicians generally allowed to prescribe off-label but companies prohibited from promoting off-label uses. Increased expectations from patients call for rational, evidence-based off-label prescribing and safety monitoring.
Marketing Mix, PLC, SWOT Analysis - LIPITOR
A study research report on marketing mix, product life cycle and SWOT analysis for a iconic pharmaceutical brand, Lipitor.
Marketing of a pharma (Basic)
this is just powerpoint of the report on a pharma company this was to present in the class and for the ease to understand the research of principle of marketing in institute of business management IoBM
Case study on merck
Merck is facing losing patents on some major drugs like Vasotac and Mevacor. Possible solutions are mergers or focusing on innovation. Merck's new product process was previously slow to respond to competitors, but it now develops cross-functional teams early in the process. Developing specialized patented drugs helps Merck capture new markets. However, drug development faces risks if products fail trials or competitors launch first. The pharmaceutical industry faces challenges like patent expirations and increasing drug resistance. Porter's five forces analysis shows barriers to entry are high in pharmaceuticals due to R&D costs and required scale, while buyers have significant bargaining power.
Generic drug and WTO
Generic drugs provide the same clinical benefits as their brand-name counterparts at a lower cost. The document discusses the definition of generic drugs and the regulatory process for approval, including how generics are proven to be bioequivalent to the original drug but do not need to repeat clinical trials. It also addresses India's policies promoting generic drugs, the TRIPS agreement and its implications for international drug access, and initiatives like the Doha Declaration aimed at balancing intellectual property protections with public health needs.
Generic drug ppt
The document discusses the generic drug development process and the Hatch-Waxman Act. It defines generic drugs as being identical to brand name drugs in active ingredients, dosage form, quality and therapeutic effects. The generic drug approval process involves submitting an Abbreviated New Drug Application to the FDA that demonstrates bioequivalence to the brand name drug. The Hatch-Waxman Act established the modern system of generic drug regulation, providing incentives for generic drugs to gain FDA approval and compensating brand name drugs for patent time lost during regulatory review.
Drug medicine pharmaceuticals
This document defines and explains common terminology used in the pharmaceutical field. It discusses terms like drug, medicine, classifications of drugs and medicines. It also defines other key terms including monograms, patents, brand names, generic names, over-the-counter drugs, narcotic drugs, biological drugs, and the nature of drugs. Traditional and herbal medicines are also described. The document provides references for each terminology defined.
Eugene D. Fanning Center for Business Communication 01-01Men.docx
The document discusses Bayer Corporation's recall of products containing the ingredient phenylpropanolamine (PPA) due to health concerns raised by the FDA. It provides background on Bayer, describes the controversy around PPA and studies linking it to risks of hemorrhagic stroke. It outlines the FDA's process for evaluating drug risks and requesting voluntary recalls. When the FDA recommended discontinuing PPA use, some media incorrectly reported this as an outright ban, which failed to anticipate how this would impact perception of Bayer's Alka-Seltzer brand.
Are there reasons for believing that the profitability of the industry might ...
Are there reasons for believing that the profitability of the industry might ...Global Study Solutions - 9901366442
Managers in the pharmaceutical industry face both opportunities and threats due to a dynamic environment. Demand for pharmaceuticals has grown steadily for decades due to demographics and successful new drugs can be highly profitable. However, developing new drugs takes 10-15 years and costs $800 million on average, with many failing. Additionally, incumbent firms face challenges such as upcoming patent expirations, potential price controls, and reduced prices negotiated by large health providers.Drug Bulletin of Nepal
The document summarizes several important drug regulatory news and safety updates from regulatory authorities including Health Canada and the US FDA. It provides warnings and updates to healthcare professionals in Nepal about potential drug interactions and risks, including:
1) The risk of high anion gap metabolic acidosis with concomitant use of flucloxacillin and paracetamol.
2) The possible risk of hypothyroidism in infants given iodine-containing contrast agents.
3) The removal of a boxed warning about asthma deaths for medicines containing inhaled corticosteroids and long-acting beta agonists.
4) The rare risk of subacute cutaneous lupus erythematosus with proton
The science of hope
This document discusses the challenges and strategies for successful orphan drug development. It notes that despite small patient populations, orphan drug development has grown significantly due to regulatory incentives. However, orphan drug development faces challenges including difficulties designing studies due to lack of disease information, problems recruiting small patient populations, and regulatory complexities. The document recommends three strategies for overcoming these challenges: 1) partnering with experienced CROs knowledgeable in rare diseases, 2) engaging key opinion leaders to help with sites and education, and 3) allowing flexibility in protocols and budgets to address unexpected changes common in rare disease studies. Overall the document outlines the benefits and hurdles of orphan drug development and provides guidance on navigating clinical and regulatory obstacles.
Generic Drugs Michael Mc Namara May 12
The document discusses generic drugs and biosimilars. It provides biographical information about the speaker and outlines key questions about generics that will be addressed. Generic drugs are defined as comparable but not identical to brand name drugs in dosage, strength, quality and performance. Biosimilars are similar to biologic drugs but require more extensive testing than generics due to their complex nature. The market for generic drugs is large and growing, particularly in emerging markets, as major drugs lose patent protection.
Submodule 3.1 Final June 2007
This document discusses marketing strategies used by the pharmaceutical industry, including how they target physicians and consumers. It outlines common marketing tactics like the "4 P's" of product, price, promotion and placement. It also discusses how companies may indirectly influence prescribing through clinical guidelines and gifts/payments to physicians. The legal boundaries of promoting on-label versus off-label drug use are covered, as well as ethical standards to limit physician interactions with industry.
Similar to Patents and Generics.pptx (20)
Originators and Princeps: How to face Biosimilars and Generics
Originators and Princeps: How to face Biosimilars and Generics
Eugene D. Fanning Center for Business Communication 01-01Men.docx
Eugene D. Fanning Center for Business Communication 01-01Men.docx
Are there reasons for believing that the profitability of the industry might ...
Are there reasons for believing that the profitability of the industry might ...
Recently uploaded
All info about Diabetes and how to control it.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Identifying Major Symptoms of Slip Disc.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
Recently uploaded (20)
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Patents and Generics.pptx
- 12. Actually, generic drugs are only cheaper because the manufacturers have not had the expenses of developing and marketing a new drug. When a company brings a new drug onto the market, the firm has already spent substantial money on research, development, marketing and promotion of the drug. A patent is granted that gives the company that developed the drug an exclusive right to sell the drug as long as the patent is in effect.
- 13. NAMING BRANDED AND GENERIC DRUG • An example of a generic drug, one used for diabetes, is metformin. A brand name for metformin is Glucophage. (Brand names are usually capitalized while generic names are not.) A generic drug, one used for hypertension, is metoprolol, whereas a brand name for the same drug is Lopressor. References: https://www.fda.gov/drugs/generic-drugs/generic-drug-facts https://www.fda.gov/drugs/generic-drugs/what-approval-process-generic-drugs